Discovery of an adjuvant that resensitizes polymyxin B-resistant bacteria

Bioorg Med Chem. 2024 Jan 1:97:117541. doi: 10.1016/j.bmc.2023.117541. Epub 2023 Dec 6.

Abstract

Infections caused by antibiotic-resistant bacteria are a major threat to health, increasing mortality rates and straining health systems worldwide. Adjuvants targeted to beta-lactamase function are able to resensitize bacteria to beta-lactam antibiotics, but there is comparatively little research into the use of adjuvants against other resistance phenotypes. In this study, we performed a high-throughput screen of 74 natural products to identify adjuvants that synergized with antibiotics to eradicate resistant Gram-negative bacteria. From this, we identified six adjuvant hits which restored growth inhibition when combined with the relevant antibiotic, and pursued a lead candidate, perforone, which possessed selective adjuvant activity in combination with polymyxin B against polymyxin-resistant Escherichia coli cells. These results suggest that pairing adjuvants with antibiotics could be a useful general intervention against resistant bacteria, helping to mitigate the effects of antimicrobial resistance.

Keywords: Adjuvants; Antibiotics; Antimicrobial resistance; Membrane permeabilizers; Perforone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Pharmaceutic / pharmacology
  • Anti-Bacterial Agents* / pharmacology
  • Bacteria
  • Drug Resistance, Multiple, Bacterial
  • Escherichia coli
  • Gram-Negative Bacteria
  • Microbial Sensitivity Tests
  • Polymyxin B* / pharmacology
  • Polymyxins / pharmacology

Substances

  • Polymyxin B
  • Anti-Bacterial Agents
  • Polymyxins
  • Adjuvants, Pharmaceutic